Vitamin D3: An ever green molecule

Frontiers in Bioscience - Scholar

Volumn 5 S, Issue 1, 2013, Pages 247-260

  Di Rosa, Michele ^a   Malaguarnera, Lucia ^a   Nicolosi, Anna ^a   Sanfilippo, Cristina ^a   Mazzarino, Clorinda ^a   Pavone, Piero ^a   Berretta, Massimiliano ^b   Cosentino, Stefano ^a   Cacopardo, Bruno ^a   Pinzone, Marilia Rita ^a   Nunnari, Giuseppe ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Diet; Immune cells; Macrophage; Review; Vitamin D3

Indexed keywords

BETA DEFENSIN; C REACTIVE PROTEIN; CALCIDIOL 1 MONOOXYGENASE; CALCIFEDIOL; CALCITRIOL; COLECALCIFEROL; COLECALCIFEROL RECEPTOR; ERGOCALCIFEROL; INTERLEUKIN 12; RETINOID X RECEPTOR; RETINOID X RECEPTOR ALPHA; RNA POLYMERASE II; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D BINDING PROTEIN;

ALTITUDE; ANTIGEN PRESENTING CELL; APOPTOSIS; ATHEROSCLEROSIS; B LYMPHOCYTE; BACTERICIDAL ACTIVITY; BREAST CANCER; CALCIUM ABSORPTION; CALCIUM METABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CANCER; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA BINDING; DNA DAMAGE; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; IMMUNOCOMPETENT CELL; KERATINOCYTE; LIGAND BINDING; MACROPHAGE; MELANOCYTE; MELANOGENESIS; MITOCHONDRIAL TARGETING SIGNAL; MONOCYTE; MULTIPLE SCLEROSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OSTEOPOROSIS; PROSTATE CANCER; REVIEW; SEASONAL VARIATION; SUN EXPOSURE; T LYMPHOCYTE; TUBERCULOSIS; TUMOR GROWTH; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET C RADIATION; VITAMIN D DEFICIENCY; VITAMIN D RESPONSIVE ELEMENT; VITAMIN METABOLISM; VITAMIN SUPPLEMENTATION; ANIMAL; IMMUNOLOGY; INFECTION; METABOLISM; NEOPLASM; SKIN;

VERTEBRATA;

ANIMALS; CHOLECALCIFEROL; HUMANS; INFECTION; NEOPLASMS; OSTEOPOROSIS; SKIN;

EID: 84883235675     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: None     Document Type: Review

References (146)

1. MF Holick. Phylogenetic and evolutionary aspects of vitamin D from phytoplankton to humans. In: Pang PKT, Schreibman MP, editors. Vertebrate endocrinology: fundamentals and biomedical implications. Vol 3. Orlando: Academic Press: 7-43 (1989)
2. J Moan, A Dahlback, RB Setlow: Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 70(2), 243-247 (1999)
3. M Ranson, S Posen, RS Mason: Human melanocytes as a target tissue for hormones: in vitro studies with 1alpha25, dihydroxyvitamin D3, alphamelanocyte stimulating hormone, and betaestradiol. J Invest Dermatol 91, 5938 (1988)
4. RM Sayre, JC Dowdy, J Shepherd, I Sadig, A Bager, and N Kollias: Vitamin D Production by Natural and Artificial Sources. Orlando, Florida, Photo Medical Society Meeting. 311998. Ref Type: Conference Proceeding.(1998)
5. MF Holick: The cutaneous photosynthesis of previtamin D3: a unique photoendocrine system. J Invest Dermatol 77, 518 (1981)
6. LY Matsuoka, J Wortsman, JG Haddad, P Kolm, BW Hollis: Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol 127, 5368 (1991)
7. LY Matsuoka, J Wortsman, JG Haddad, BW Hollis: In vivo threshold for cutaneous synthesis of vitamin D3. J Lab Clin Med 114, 3015 (1989)
8. Season, latitude, and ability of sunlight to promote synthesis of vitamin D3 in skin. Nutr Rev 47, 2523 (1989)
9. AR Webb, L Kline, MF Holick: Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67, 3738 (1988)
10. Dorland's Illustrated Medical Dictionary, under Vitamin (Table of Vitamins)
11. SD Crissey, KD Ange, KL Jacobsen, KA Slifka, PE Bowen, M Stacewicz-Sapuntzakis, CB Langman: Serum concentrations of lipids, vitamin d metabolites, retinol, retinyl esters, tocopherols and selected carotenoids in twelve captive wild felid species at four zoos. The Journal of nutrition 133 (1), 160-166 (2003)
12. F Walter: The Parathyroid Glands and Vitamin F. Medical Physiology: A Cellular And Molecular Approach. Elsevier/Saunders 1094 (2003)
13. JB Cheng, MA Levine, NH Bell, DJ Mangelsdorf, DW Russell: Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci U S A 101 (20), 7711-7715 (2004)
14. About Vitamin D Including Sections: History, Nutrition, Chemistry, Biochemistry, and Diseases. University of California Riverside (1998)
15. MF Holick: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. The American journal of clinical nutrition 80 (6S), 1678S-1688S (2004)
16. M Di Rosa, M Malaguarnera, F Nicoletti, L Malaguarnera: Vitamin D3: a helpful immuno-modulator. Immunology 134(2), 123-139 (2011)
17. A Chawla, J Repa, RM Evans, and DJ Mangelsdorf: Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870 (2001)
18. R Lin, and JH White: The pleiotropic actions of vitamin D. BioEssays 26, 21-28 (2004)
19. N Rochel, JM Wurtz, A Mitschler, B Klaholz, and D Moras: The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand.Mol Cell 5, 173-179 (2000)
20. L Drocourt, JC Ourlin, JM Pascussi, P Maurel, and MJ Vilarem: Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem 277, 25125-25132 (2002)
21. PD Thompson, PW Jurutka, GK Whitfield, SM Myskowski, KR Eichhorst, CE Dominguez, CA Haussler, and MR Haussler: Liganded VDR induces CYP3A4 in small intestinal and colon cancer cells via DR3 and ER6 vitamin D responsive elements. Biochem Biophys Res Commun 299, 730-738 (2002)
22. KE Thummel, C Brimer, K Yasuda, J Thottassery, T Senn, Y Lin, H Ishizuka, E Kharasch, J Schuetz, and E Schuet: Transcriptional control of intestinal cytochrome P-4503A by 1alpha,25-dihydroxyvitamin D3. Mol Pharmacol 60, 1399-1406 (2001)
23. L Tavera-Mendoza, TT Wang, B Lallemant, R Zhang, Y Nagai, V Bourdeau, M Ramiro Calderon, J Desbarats, S Mader, and JH White: Convergence of vitamin D and retinoic acid signaling at a common hormone response element. EMBO Rep 7, 180-185 (2006)
24. FJ Dilworth, P Chambon: Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription. Oncogene 20, 3047-3054 (2001)
25. CK Glass, and MG Rosenfeld: The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev 14, 121-141 (2000)
26. NJ McKenna, and BW O'Malley: Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108, 465-474 (2002)
27. C Rachez, and LP Freedman: Mechanisms of gene regulation by vitamin D-3 receptor: a network of coactivator interactions. Gene 246, 9-21 (2000)
28. MG Rosenfeld, and CK Glass: Coregulator codes of transcriptional regulation by nuclear receptors. J Biol Chem 276, 36865-36868 (2001)
29. I Alroy, T Towers, and LP Freedman: Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol Cell Biol 15, 5789-5799 (1995)
30. A Takeuchi, G Reddy, T Kobayashi, T Okano, J Park, and S Sharma: Nuclear factor of activated T cells (NFAT) as a molecular target for 1,25-dihydroxyvitamin D3-mediated effects. J Immunol 160, 209-218 (1998)
31. S Kim, M Yamazaki, LA Zella, NK Shevde, and JW Pike: Activation of receptor activator of NF-kappa B ligand gene expression by 1,25-dihydroxyvitamin D-3 is mediated through multiple long-range enhancers. Mol Cell Biol 26, 6469-6486 (2006)
32. JS Adams, OP Sharma, MA Gacad, and FR Singer: Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Investig 72, 1856-1860 (1983)
33. L Overbergh, B Decallonne, D Valckx, A Verstuyf, J Depovere, J Laureys, O Rutgeerts, R Saint-Arnaud, R Bouillon, and C Mathieu: Identification and immune regulation of 25-hydroxyvitamin D-1-Alpha-hydroxylase n murine macrophages. Clin Exp Immunol 120, 139-146 (2000)
34. L Overbergh, K Stoffels, M Waer, A Verstuyf, R Bouillon, and C Mathieu: Immune regulation of 25-hydroxyvitamin D-1 alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferongammamediated. J Clin Endocrinol Metab 91, 3566-3574 (2006)
35. K Stoffels, L Overbergh, A Giulietti, L Verlinden, R Bouillon, and C Mathieu: Immune regulation of 25-hydroxyvitamin-D-3-1 alpha-hydroxylase in human monocytes. J Bone Miner Res 21, 37-47 (2006)
36. PT Liu, S Stenger, HY Li, L Wenzel, BH Tan, SR Krutzik, MT Ochoa, J Schauber, K Wu, C Meinken, DL Kamen, M Wagner, R Bals, A Steinmeyer, U Zugel, RL Gallo, D Eisenberg, M Hewison, BW Hollis, JS Adams, BR Bloom, and RL Modlin: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773 (2006)
37. MF Holick, M Garabedian: Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. In: Favus MJ, ed. Primer on the metabolic bone diseases and disorders of mineral metabolism, 6th ed. Washington, DC: American Society Bone and Mineral Research, 129-137 (2006)
38. HF DeLuca: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 80(Suppl), 1689S-1696S (2004)
39. S Ren, L Nguyen, S Wu, C Encinas, JS Adams, and M Hewison: Alternative splicing of vitamin D-24-hydroxylase: a novel mechanism for the regulation of extrarenal 1,25-dihydroxyvitamin D synthesis. J Biol Chem 280, 20604-20611 (2005)
40. Institute of Medicine, Food and Nutrition Board. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, (1997)
41. GL Lensmeyer, DA Wiebe, N Binkley, MK Drezner: HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem 52, 1120-1126 (2006)
42. PH Mattila, VI Piironen, EJ Uusi-Rauva, PE Koivistoinen: Vitamin D contents in edible mushrooms. J Agric Food Chem 42, 2449-2453 (1994)
43. MS Calvo, SJ Whiting, CN Barton: Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 80, 1710S-1716S (2004)
44. A Khajavi, GH Amirhakimi: The rachitic lung: pulmonary findings in 30 infants and children with malnutritional rickets. Clin Pediatr 16, 36-38 (1977)
45. AR Martineau, FU Honecker, RJ Wilkinson, CJ Griffiths: Vitamin D in the treatment of pulmonary tuberculosis. J Steroid Biochem Mol Biol 103, 793-798 (2007)
46. PA Danai, S Sinha, M Moss, MJ Haber, GS Martin: Seasonal variation in the epidemiology of sepsis. Crit Care Med 35, 410-415 (2007)
47. WB Grant: Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J 27, 853 (2008)
48. JJ Cannell, R Vieth, JC Umhau: Epidemic influenza and vitamin D. Epidemiol Infect 134, 1129-1140 (2006)
49. MF Holick: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81, 353-373 (2006)
50. KK Thomas, DM Lloyd-Jones, RI Thadhani: Hypovitaminosis D in medical inpatients. N Engl J Med 338,777-783 (1998)
51. MF Holick, ES Siris, N Binkley: Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90, 3215-3224 (2005)
52. RP Heaney, MS Dowell, CA Hale, A Bendich: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22, 142-146 (2003)
53. B Dawson-Hughes, RP Heaney, MF Holick, P Lips, PJ Meunier, R Vieth: Estimates of optimal vitamin D status. Osteoporos Int 16, 713-716 (2005)
54. R Vieth: Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 89-90, 575-579 (2004)
55. JM Pettifor: Vitamin D deficiency and nutritional rickets in children in vitamin D. In: Feldman D, Pike JW, Glorieux FH, eds. Vitamin D. 2nd ed. Boston: Elsevier Academic Press, 1065-1084 (2005)
56. MC Chapuy, P Preziosi, MMaamer: Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 7,439-443 (1997)
57. S Boonen, HA Bischoff-Ferrari, C Cooper: Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 78, 257-270 (2006)
58. MF Holick: Resurrection of vitamin D deficiency and rickets. J Clin Invest 116, 2062-2072 (2006)
59. P Lips, D Hosking, K Lippuner: The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260, 245-254 (2006)
60. SH Sedrani: Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Ann Nutr Metab 28, 181-185 (1984)
61. JJ McGrath, MG Kimlin, S Saha, DW Eyles, AV Parisi: Vitamin D insufficiency in south-east Queensland. Med J Aust 174, 150-151 (2001)
62. RP Heaney, MS Dowell, CA Hale, A Bendich: Calcium absorption varies within the reference range for serum 25-hydroxyvitamin. J Am Coll Nutr 22, 142-146 (2003)
63. MF Holick: High prevalence of vitamin D inadequacy and implications for health.Mayo Clin Proc 81, 353-373 (2006)
64. MC Chapuy, ME Arlot, F Duboeuf: Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327, 1637-1642 (1992)
65. FM Gloth, JM Lindsay, LB Zelesnick, WB Greenough: Can vitamin D deficiency produce an unusual pain syndrome? Arch Intern Med 151, 1662-1664 (1991)
66. AO Malabanan, AK Turner, MF HolicK: Severe generalized bone pain and osteoporosis in a premenopausal black female: effect of vitamin D replacement. J Clin Densitometr 1, 201-204 (1998)
67. RD Semba, DK Houston, S Bandinelli, K Sun, A Cherubini, AR Cappola, JM Guralnik, L Ferrucci: Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 64(2), 203-209 (2010)
68. S Boonen, HA Bischoff-Ferrari, C Cooper: Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence. Calcif Tissue Int 78, 257 (2006)
69. P Lips: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22, 477-501 (2001)
70. T Thom, N Haase, W Rosamond: Heart Disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113, 85-151 (2006)
71. JC Gallagher, D Goldgar, A Moy: Total bone calcium in women: Effect of age and menopause status. J Bone Min Res 2, 491-496 (1987)
72. JC Gallagher, BL Riggs, HF DeLuca: Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 51(6), 1359-1364 (1980)
73. CE Daniels: Estrogen therapy for osteoporosis prevention in post-menopausal women. Pharmacy Update-NIH (2001)
74. L Fievez, M Michels: Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: effects of antiretroviral therapy. AIDS Res Hum Retroviruses 24, 1375-1382 (2008)
75. A Zittermann: Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 92, 39-48 (2006)
76. SG Rostand: Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 30, 150-156 (1997)
77. R Krause, M Buhring, W Hopfenmuller, MF Holick, AM Sharma: Ultraviolet B and blood pressure. Lancet 352, 709-710 (1998)
78. A Zittermann, SS Schleithoff, G Tenderich, HK Berthold, R Korfre, P Stehle: Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 41, 105-112 (2003)
79. GM London, AP Guerin, SJ Marchais, F Métivier, B Pannier, H Adda: Arterial media calcification in end-stage renal disease: impact on all cause and cardiovascular mortality. Nephrol Dial Transplant 18, 1731-1740 (2003)
80. FL Apperly: The relation of solar radiation to cancer mortality in North America. Cancer Res 1, 191-195 (1941)
81. ET Chang, KE Smedby, H Hjalgrim: Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst 97, 1466-1474 (2005)
82. E Giovannucci: Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol 624, 31-42 (2008)
83. CF Garland, FC Garland, ED Gorham: The role of vitamin D in cancer prevention. Am J Public Health 96(2), 252-261 (2006)
84. CF Garland, FC Garland: Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol 9(3), 227-231 (1980)
85. CL Hanchette, GG Schwartz: Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 70(12), 2861-2869 (1992)
86. GG Schwartz, BS Hulka: Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis). Anticancer Res 10(5A), 1307-1311 (1990)
87. CF Garland, ED Gorham, SB Mohr: Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 103(3-5), 708-711 (2007)
88. MY Wei, CF Garland, ED Gorham: Vitamin D and prevention of colorectal adenoma: a meta-Analysis. Cancer Epidemiol Biomarkers Prev 17(11), 2958-2969 (2008)
89. L Yin, N Grandi, E Raum: Meta-Analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther 30(2), 113-125 (2009)
90. K Ng, JA Meyerhardt, K Wu: Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26(18), 2984-2991 (2008)
91. KK Deeb, DL Trump, CS Johnson: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7(9), 684-700 (2007)
92. KC Chiang, TC Chen: Vitamin D for the prevention and treatment of pancreatic cancer. World J Gastroenterol 15(27), 3349-3354 (2009)
93. J Welsh: Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res 22(Suppl2), V86-90 (2007)
94. MJ Campbell, E Elstner, S Holden: Inhibition of proliferation of prostate cancer cells by a 19-norhexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol 19(1), 15-27 (1997)
95. E Gocek, GP Studzinski: Vitamin D and differentiation in cancer. Crit Rev Clin Lab Sci 46(4), 190-209 (2009)
96. J Welsh: Targets of vitamin D receptor signaling in the mammary gland. J Bone Miner Res 22(Suppl2), V86-90 (2007)
97. Blutt SE, McDonnell TJ, Polek TC: Calcitriol-induced apoptosis in LNCaP cells is blocked by overexpression of Bcl-2. Endocrinology;141(1):10-17 (2000)
98. T Ylikomi, I Laaksi, YR Lou: Antiproliferative action of vitamin D. Vitam Horm 64, 357-406 (2002)
99. K Koli, J Keski-Oja: 1alpha,25-dihydroxyvitamin D3 and its analogues downregulate cell invasion-Associated proteases in cultured malignant cells. Cell Growth Differ 11(4), 221-229 (2000)
100. XP Yu, T Bellido, SC Manolagas: Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A 92(24),10990-10994 (1995)
101. H Harant, B Wolff, IJ Lindley: 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett 436(3), 329-334 (1998)
102. M Stio, M Martinesi, S Bruni: The vitamin D analogue TX 527 blocks NFkappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J Steroid Biochem Mol Biol 103(1), 51-60 (2007)
103. M Schwab, V Reynders, S Loitsch: Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling. Mol Immunol 44(15), 3625-3632 (2007)
104. G Ulett: Geographic distribution of multiple sclerosis. Dis Nerv Syst 9, 342 (1948)
105. IA van der Mei, AL Ponsonby, L Blizzard: Past exposure to sun, skin phenotype, and risk of multiple sclerosis: casecontrol study. BMJ 327, 316 (2003)
106. M Soilu-Hanninen, L Airas, I Mononen: 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 11, 266-271 (2005)
107. AF Embry, LR Snowdon, R Vieth: Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 48, 271-272 (2000)
108. MT Cantorna, J Humpal-Winter, F DeLuca: Dietary calcium is a major factor in 1-25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. J Nutr 129, 1966-1971 (1999)
109. J Smolders, J Damoiseaux, P Menheere: Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 194, 7-17 (2008)
110. KL Munger, LI Levin, BW Hollis: Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832-2838 (2006)
111. R Vieth: Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69, 842-856 (1999)
112. SM Kimball, MR Ursell, P O'Connor: Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 86, 645-651 (2007)
113. JM Burton, S Kimball, R Vieth, M Dosch, R Cheung, D Gagne, C D'Souza, M Ursell, P O'Connor: A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74, 1852-1859 (2010)
114. MR Von Essen: Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11, 344-349 (2010)
115. GA Rook, J Steele, L Fraher: Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57, 159-163 (1986)
116. AJ Crowle, EJ Ross, MH May: Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages. Infect Immun 55, 2945-2950 (1987)
117. PT Liu, S Stenger, H Li: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773 (2006)
118. TT Wang, FP Nestel, V Bourdeau: Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immun 173, 2909-2912 (2004)
119. J Wehkamp, J Schauber, EF Stange: Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 23, 32-38 (2007)
120. LM Sly, M Lopez, WM Nauseef, NE Reiner: 1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 276, 35482-35493 (2001)
121. Y Tachi, H Shimpuku, Y Nosaka: Vitamin D receptor gene polymorphism is associated with chronic periodontitis. Life Sci 73, 3313-3321 (2003)
122. MH Malik, F Jury, A Bayat, WE Ollier, PR Kay: Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Ann Rheum Dis 66, 1116-1120 (2007)
123. MT Cantorna, S Yu, D Bruce: The paradoxical effects of vitamin D on type 1 mediated immunity. Mol Aspects Med 29, 369-375 (2008)
124. JJ Cannell, R Vieth, JC Umhau: Epidemic influenza and vitamin D. Epidemiol Infect 134, 1129-1140 (2006)
125. M Rodríguez, B Daniels, S Gunawardene, GK Robbins: High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 25, 9-14 (2009)
126. RI Connor, WF Rigby: 1 alpha,25-Dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem Biophys Res Commun 176, 852-859 (1991)
127. M Kizaki, Y Ikeda, KJ Simon, M Nanjo, HP Koeffler: Effect of 1,25-dihydroxyvitamin D3 and its analogs on human immunodeficiency virus infection in monocytes/ macrophages. Leukemia 7, 1525-1530 (1993)
128. P Bergman, L Walter-Jallow, K Broliden, B Agerberth, J Söderlund: The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5, 410-415 (2007)
129. C Haug, F Muller, SS Froland, M Degre, P Aukrust: Serum level of vitamin D3 correlates with the degree of immune deficiency in HIV infection. International Conference on AIDS. Int Conf AIDS: 9, 197 (1993)
130. L Adorini: Intervention in autoimmunity: The potential of vitamin D receptor agonists. Cell Immunol 233, 115-124 (2005)
131. DM Provvedini, CD Tsoukas, LJ Deftos, SC Manolagas: 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science 221, 1181-1183 (1983)
132. E Van Etten, C Mathieu: Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Ster Biochem Mol Biol 97, 93-101 (2005)
133. S Nesby-O'Dell, KS Scanlon, ME Cogswell, C Gillespie, BW Hollis, AC Looker, C Allen, C Doughertly, EW Gunter, aEA Bowman: Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr 76, 187-192 (2002)
134. WW Stead, JW Senner, WT Reddick, JP Lofgren: Racial differences in sensitivity to infection by Mycobacterium tuberculosis. N Engl J Med 322, 422-427 (1990)
135. PT Liu, S Stenger, HY Li, L Wenzel, BH Tan, SR Krutzik, MT Ochoa, J Schauber, K Wu, C Meinken, DL Kamen, M Wagner, R Bals, A Steinmeyer, U Zugel, RL Gallo, D Eisenberg, M Hewison, BW Hollis, JS Adams, BR Bloom, RL Modlin: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773 (2006)
136. K Stoffels, L Overbergh, A Giulietti, L Verlinden, R Bouillon, C Mathieu: Immune regulation of 25-hydroxyvitamin-D-3-1 alpha-hydroxylase in human monocytes. J Bone Miner Res 21, 37-47 (2006)
137. KN Evans, H Taylor, D Zehnder, MD Kilby, JN Bulmer, F Shah, JS Adams, M Hewison: Increased expression of 25-hydroxyvitamin D-1 alpha-hydroxylase in dysgerminomas-A novel form of humoral hypercalcemia of malignancy. Am J Pathol 165, 807-813 (2004)
138. KN Evans, L Nguyen, J Chan, BA Innes, JN Bulmer, MD Kilby, M Hewison: Effects of 25-hydroxyvitamin D-3 and 1,25-dihydroxyvitamin D-3 on cytokine production by human decidual cells. Biol Reprod 75, 816-822 (2006)
139. MC Iannuzzi, BA Rybicki, AS Teirstein: Medical progress: sarcoidosis. N Engl J Med 357, 2153-2165 (2007)
140. F Oberg, J Botlin, K Nilsson: Functional antagonisms between vitamin-D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol 150, 3487-3495 (1993)
141. J Schauber, RA Dorschner, AB Coda, AS Buchau, PT Liu, D Kiken, YR Helfrich, S Kang, HZ Elalieh, A Steinmeyer, U Zugel, DD Bikle, RL Modlin, RL Gallo: Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Investig 117, 803-811 (2007)
142. P Bergman, L Walter-Jallow, K Broliden, B Agerberth, J Soderlund: The antimicrobial peptide LL-37 inhibits HIV-1 replication. Curr HIV Res 5, 410-415 (2007)
143. L Steinstraesser, B Tippler, L Mertens, E Lamme, HH Homann, M Lehnhardt, O Wildner, HU Steinau, K Uberla: Inhibition of early steps in the lentiviral replication cycle by cathelicidin host defense peptides. Retrovirology 2, Art 2 (2005)
144. MR von Essen, M Kongsbak, P Schjerling, K Olgaard, N Odum, C Geisler: Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 11(4), 344-349 (2010)
145. RT Abraham, A Weiss: Jurkat T cells and development of the T-cell receptor signalling paradigm. Nat Rev Immunol 4, 301-308 (2004)
146. JE Smith-Garvin, GA Koretzky, MS Jordan: T cell activation. Annu Rev Immunol 27, 591-619 (2009)